Shlomo Yanai - Perrigo Company Independent Director Nominee

PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

Mr. Shlomo Yanai is Independent Director Nominee of the Company. He served as Chief Executive Officer and as President of Teva Pharmaceutical Industries Ltd., a global pharmaceutical company, from March 2007 to May 2012. He was an independent director of Sagent Pharmaceuticals, Inc., since April 2015 a director of Quinpario Acquisition Corporationration 2 since November 2014 a director and NonExecutive Chairman of Cambrex since November 2012 and a director of Lumenis Ltd. since December 2012. He also serves as a member of an advisory board at Paragon Pharmaceuticals, LLC a member of the International Advisory Board of the MBA program of BenGurion University as well as an honorary member of the board of the Universitys Institute for Policy and Strategy of the Interdisciplinary Center. Mr. Yanai also served 32 years with the Israeli Defense forces, retiring in 2001 with the rank of Major General.
Age: 62        
353 1 709 4000

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62 B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives


Kalpana MorpariaDr Reddys Laboratories Ltd
Christine PoonRegeneron Pharmaceuticals
Omkar GoswamiDr Reddys Laboratories Ltd
Anthony ColesRegeneron Pharmaceuticals
Sridar IyengarDr Reddys Laboratories Ltd
William DoyleZoetis
Sanjay KhoslaZoetis
Gregory NordenZoetis
Alfred GilmanRegeneron Pharmaceuticals
Bruce CarterDr Reddys Laboratories Ltd
Frank DAmelioZoetis
William YoungVertex Pharmaceuticals Incorpor
Arthur RyanRegeneron Pharmaceuticals
Leo PuriDr Reddys Laboratories Ltd
Margaret McGlynnVertex Pharmaceuticals Incorpor
James KangOrigin Agritech Limited
Allan ObermanDr Reddys Laboratories Ltd
Yingqi XiaOrigin Agritech Limited
Anupam PuriDr Reddys Laboratories Ltd
David BullockOrigin Agritech Limited
William SteereZoetis

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Current Sentiment - PRGO

Perrigo Company Investor Sentiment

Most of Macroaxis users are at this time bullish on Perrigo Company Plc. What is your perspective on investing in Perrigo Company Plc? Are you bullish or bearish?
98% Bullish
2% Bearish

Currently Active Assets on Macroaxis

Purchased a lot of shares of
few hours ago
Traded for 152.08
Purchased over 70 shares of
few hours ago
Traded for 35.0
Purchased few shares of
few hours ago
Traded for 177.94
Purchased over 40 shares of
few hours ago
Traded for 69.6
Purchased few shares of
few hours ago
Traded for 190.39
Additionally take a look at Your Equity Center. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.